Publications:

Pancewicz-Wojtkiewicz J, Eljaszewicz A, Kowalczuk O, Niklinska W, Charkiewicz R, Kozłowski M, Miasko A, Moniuszko M. Prognostic significance of Notch ligands in patients with non-small cell lung cancer. Oncol Lett. 2017;13:506-510. doi: 10.3892/ol.2016.5420.

Łukaszewicz-Zając M., Kulczyńska-Przybik A., Muszyński P., Kozłowski M, Szmitkowski M., Mroczko B. Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer. Pol Arch Med Wewn. 2016;126:854-861.

Łukaszewicz-Zając M., Mroczko B., Kozłowski M., Szmitkowski M. Stem cell factor in the serum of patients with esophageal cancer in relation to its histological types.
Czasopismo: Arch Med Sci. 2016;126:854-861.

Łukaszewicz-Zając M., Mroczko B., Kozłowski M., Szmitkowski M.. The serum concentrations of chemokine CXCL12 and its specific receptor CXCR4 in patients with esophageal cancer. Dis Markers. 2016;2016:7963895,7 pp

Charkiewicz R., Pilz L., Sulewska A., Kozłowski M., Niklińska W., Moniuszko M.,  Reszeć J., Manegold C, Nikliński J. Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies.Int J Cancer. 2016;138:689-697.

Juchniewicz A., Niklińska W., Kowalczuk O., Laudański W., Sulewska A., Dzięgielewski P.,  Milewski R., Naumnik W., Kozłowski M., Nikliński J. Prognostic value of vascular endothelial growth factor-C and podoplanin mRNA expression in esophageal cancer.
Oncol Lett. 2015;10:3668-3674.

Kowalczuk O., Kozłowski M., Milewski R., Minarowski Ł., Reszeć J. Significance of EGFR signaling pathway genetic alterations in radically resected non-small cell lung cancers from a Polish cohort. One institutional study. Adv Med Sci. 2015;60:277-286.
 

Kowalczuk O., Burzykowski T., Niklińska W., Kozłowski M., Chyczewski L., Nikliński J.
CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes. Tumor Biol. 2014;35:4619-4628.

Kowalczuk O., Kozłowski M., Niklińska W., Kiśluk J., Niklińska B., Nikliński J.
Increased MET gene copy number but not mRNA level predicts postoperative recurrence in patients with non-small cell lung cancer. Trans Oncol. 2014;7:605-612.

Baranowska-Kuczko M., Kozłowska H., Kozłowski M., Schlicker E., Kloza M., Surażyński A., Grzęda E., Malinowska B. Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries. Naunyn Schmiedeberg Archiv Pharmacol. 2014:387:477-486.

Kozłowski M., Niklińska W, Naumnik W., Laudański W., Milewski R., Nikliński J.
Intratumoral lymphatic vessel density, and intratumoral and peritumoral lymphatic vessel invasion as predictive factors of lymph node metastasis and prognostic factors in esophageal cancer. Kardiochir Torakochir Pol. 2013;10:120-129.
 

Charkiewicz R., Niklińska W., Zalewski G., Charkiewicz A., Kozłowski M., Sulewska A.,  Chyczewski L. New monoallelic combination of KRAS gene mutations in codons 12 and 13 in the lung adenocarcinoma. Adv Med Sci. 2013;58:83-89.
 

Kozłowska H., Baranowska-Kuczko M., Schlicker E., Kozłowski M., Kloza M.,  Malinowska B. Relaxation of human pulmonary arteries by PPAR gamma agonists. Naunyn Schmiedebergs Archiv Pharmacol. 2013;386:445-453.
 

Kozłowski M., Laudański W., Mroczko B., Szmitkowski M., Milewski M., Łapuć G.
Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients. Adv Med Sci.
2013;58:227-234.

Jelski W., Łaniewska-Dunaj M., Nikliński J., Kozłowski M., Laudański J., Szmitkowski M.
The alcohol dehydrogenase isoenzyme (ADH IV) as a candidate tumour marker of esophageal cancer. Acta Biochim Pol. 2013;60:489-493.